Dr Mascarenhas on the Rationale for the KRT-232-109 Study in Secondary Myelofibrosis

Press/Media

Period	17 Aug 2023

Media coverage

Title	Dr Mascarenhas on the Rationale for the KRT-232-109 Study in Secondary Myelofibrosis
Media name/outlet	OncLive
Country/Territory	United States
Date	17/08/23
URL	ct.moreover.com/?a=51573270859&p=1gw&v=1&x=-PwqHA9LA550Y1PY2FinjA
Persons	John Mascarenhas